PWE-109 Measurement of Infliximab and Anti-Infliximab Antibodies - Analytical Aspects and Clinical Implications: Abstract PWE-109 Table

109 feminism and the implications of austerity

In January 2014, the UK’s Channel 4 broadcast a series entitled ‘Benefits Street’, which followed the lives of people living on benefits in a street in Birmingham. The programme attracted a great deal of controversy, and many of the people who took part voiced their concern about the ways in which their lives had been presented. Among the various remarks about the programme there was, however, ...

Measurement of infliximab and anti-infliximab antibody levels can help distinguish maintenance versus loss of response.

Inflammatory bowel disease (IBD), comprised primarily of Crohn’s disease (CD) and ulcerative colitis (UC), is estimated to affect approximately 1 million individuals in the United States alone, with approximately 30,000 new cases diagnosed annually.1 A hallmark of this disease is chronic inflammation of the intestinal mucosa, which results in part from production of the tumor necrosis factor–α ...

2.04.84 Measurement of Serum Antibodies to Infliximab and Adalimumab

2.04.84 Measurement of Serum Antibodies to Infliximab and Adalimumab

Measurement of Serum Antibodies to Infliximab and Adalimumab

PLEASE NOTE: Contracts exclude from coverage, among other things, services or procedures that are considered investigational or cosmetic. Providers may bill members for services or procedures that are considered investigational or cosmetic. Providers are encouraged to inform members before rendering such services that the members are likely to be financially responsible for the cost of these se...